WebJan 25, 2024 · View 8 reports from 3 analysts offering long term price targets for Gland Pharma Ltd.. Gland Pharma Ltd. has an average target of 2323.33. The consensus estimate represents an upside of 81.02% from the last price of 1283.45. Reco - This broker has downgraded this stock from it's previous report. WebMar 28, 2024 · Granules India Ltd. share price moved Down by -4.48% from its previous close of Rs 283.65. GRANULES stock last traded price is 270.95 as on 28 Mar 2024 15:55. GRANULES share price trend is Down with a total of 1640402 stocks traded till now. It has touched an intraday high of Rs 284.45 and an intraday low of Rs 270.30.
NSE : GRANULES Share Price Target 2024 2024 2025 Stock …
WebGranules India Limited Share Price Today, Live NSE Stock Price: Get the latest Granules India Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results … WebCompany share prices are keep on changing according to the market conditions. The closing price of Granules India on 24-Mar-2024 18:03 is : 282.1. ... high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical … earlham city hall
GRANULES Stock Price and Chart — NSE:GRANULES — TradingView
WebApr 6, 2024 · Get Granules India Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. WebMar 3, 2024 · Exhibit 126: Granules India Ltd. - Product / Service Exhibit 127: Granules India Ltd. - Key news Exhibit 128: Granules India Ltd. - Key offerings 12.9 IOL Chemicals and Pharmaceuticals Ltd. Exhibit 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview Exhibit 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments WebJul 3, 2024 · Granules' test results showed NDMA levels above the FDA acceptable limit in one (1) out of the twelve (12) batches distributed to the US market. All other batches continue to remain within the specifications. Out of abundance of caution Granules Pharmaceuticals, Inc. has decided to voluntarily recall all twelve (12) of the distributed … earl haig secondary school toronto